Strain Information | |
---|---|
Image | |
BRC No. | RBRC05809 |
Type | Transgene |
Species | Mus musculus |
Strain name | B6.Cg-Tg(AS3_9-2k-lacZ)B |
Former Common name | AS3_9-2kb-B, B6-AS3-9-2kb-lacZ Tg#B |
H-2 Haplotype | |
ES Cell line | |
Background strain | |
Appearance | |
Strain development | Developed by Norihiro Okada, Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology in 2012. The transgene was injected into the pronuclei of B6C3F1 fertilized eggs. Three lines were generated : line B (RBRC05809), line C (RBRC05810), line D (RBRC05811). |
Strain description | AS3_9-2k-lacZ transgenic mice. |
Colony maintenance | Carrier x Noncarrier [C57BL/6JJmsSlc] |
References |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |
---|---|
Gene info | Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter Tol2Tol2 recognition sequence (Medaka)UNTol2 Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter lacZbeta-galactosidase (E. coli)UNmouse Heat Shock Protein 68 promoter, mouse AS3_9-2k sequence |
Ordering Information | |
---|---|
Donor DNA | Mouse Heat Shock Protein 68 promoter, E. coli lacZ gene, SV40 PolyA signal, Medaka Tol2 recognition sequence, Mouse AS3_9-2k sequence |
Research application | Fluorescent Proteins/lacZ System |
Specific Term and Conditions | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. (will be announced.) In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. If the DEPOSITOR/DEVELOPER judges that the research should be a collaborative work, the RECIPIENT agrees to include the DEPOSITOR/DEVELOPER as a co-author in any publications resulted by the use of the BIOLOGICAL RESOURCE during the first 2 years after deposition by the DEPOSITOR to the RIKEN BRC. The RECIPIENT must not redistribute the BIOLOGICAL RESOURCE without approval from the DEPOSITOR. The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. |
Depositor | Norihiro Okada (Tokyo Institute of Technology) |
Strain Status | Frozen sperm |
Strain Availability | Recovered litters from cryopreserved sperm (2 to 4 months) Cryopreserved sperm (within 1 month) |
Additional Info. | Necessary documents for ordering: |
BRC mice in Publications |
---|
No Data |